Don't Add Tolvaptan (Samsca) to Improve Diuresis in HF Patients

New evidence will bring up questions about the best way to diurese acute decompensated heart failure (ADHF) patients.

We know to give volume-overloaded patients IV loop diuretics (furosemide, etc). But side effects, such as renal dysfunction and electrolyte abnormalities, have created a push to find better options.

Hopes were set on tolvaptan (Samsca). It's used to treat severe hyponatremia by blocking vasopressin and increasing free water excretion.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote